WO2004012674A3 - Development of muscle mass in a mammal - Google Patents

Development of muscle mass in a mammal Download PDF

Info

Publication number
WO2004012674A3
WO2004012674A3 PCT/US2003/024365 US0324365W WO2004012674A3 WO 2004012674 A3 WO2004012674 A3 WO 2004012674A3 US 0324365 W US0324365 W US 0324365W WO 2004012674 A3 WO2004012674 A3 WO 2004012674A3
Authority
WO
WIPO (PCT)
Prior art keywords
muscle mass
mammal
development
nicotine
muscle
Prior art date
Application number
PCT/US2003/024365
Other languages
French (fr)
Other versions
WO2004012674A2 (en
Inventor
David P Summers
James Davidson
Original Assignee
Nutraceutical Dev Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31498627&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2004012674(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutraceutical Dev Corp filed Critical Nutraceutical Dev Corp
Priority to EP03767157A priority Critical patent/EP1539152A4/en
Priority to AU2003258041A priority patent/AU2003258041A1/en
Priority to CA002494506A priority patent/CA2494506C/en
Publication of WO2004012674A2 publication Critical patent/WO2004012674A2/en
Publication of WO2004012674A3 publication Critical patent/WO2004012674A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

In a method of developing muscle mass in a mammal, nicotine or nicotine acetylcholine receptor agonist (nAChR) is administered in combination with exercise to stimulate, recruit and mobilize muscle cells to a specific muscle mass.
PCT/US2003/024365 2002-08-02 2003-08-02 Development of muscle mass in a mammal WO2004012674A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP03767157A EP1539152A4 (en) 2002-08-02 2003-08-02 Development of muscle mass in a mammal
AU2003258041A AU2003258041A1 (en) 2002-08-02 2003-08-02 Development of muscle mass in a mammal
CA002494506A CA2494506C (en) 2002-08-02 2003-08-02 Development of muscle mass in a mammal

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40064902P 2002-08-02 2002-08-02
US60/400,649 2002-08-02
US47513103P 2003-06-02 2003-06-02
US60/475,131 2003-06-02

Publications (2)

Publication Number Publication Date
WO2004012674A2 WO2004012674A2 (en) 2004-02-12
WO2004012674A3 true WO2004012674A3 (en) 2004-07-22

Family

ID=31498627

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/024365 WO2004012674A2 (en) 2002-08-02 2003-08-02 Development of muscle mass in a mammal

Country Status (5)

Country Link
US (1) US7074812B2 (en)
EP (1) EP1539152A4 (en)
AU (1) AU2003258041A1 (en)
CA (1) CA2494506C (en)
WO (1) WO2004012674A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070207226A1 (en) * 2006-03-03 2007-09-06 Mowrey Daniel B Composition for enhancing muscle mass development in animals

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417205B1 (en) * 1999-07-28 2002-07-09 The Board Of Trustees Of The Leland Stanford Jr. University Nicotine in therapeutic angiogenesis and vasculogenesis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212188A (en) * 1992-03-02 1993-05-18 R. J. Reynolds Tabacco Company Method for treatment of neurodegenerative diseases
US5232932A (en) * 1992-05-21 1993-08-03 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
BR0012787A (en) * 1999-07-28 2002-07-30 Univ Leland Stanford Junior Nicotine receptor agonists in stem cell and progenitor cell recruitment
US6277855B1 (en) * 2000-04-21 2001-08-21 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with nicotinic acetylcholine receptor agonists
US20020010192A1 (en) * 2000-06-02 2002-01-24 Coe Jotham Wadsworth Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss
US6423319B1 (en) * 2000-10-04 2002-07-23 Allergan Sales, Inc. Methods for treating muscle injuries

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417205B1 (en) * 1999-07-28 2002-07-09 The Board Of Trustees Of The Leland Stanford Jr. University Nicotine in therapeutic angiogenesis and vasculogenesis

Also Published As

Publication number Publication date
US7074812B2 (en) 2006-07-11
CA2494506C (en) 2009-02-10
AU2003258041A8 (en) 2004-02-23
WO2004012674A2 (en) 2004-02-12
EP1539152A2 (en) 2005-06-15
AU2003258041A1 (en) 2004-02-23
EP1539152A4 (en) 2006-10-18
CA2494506A1 (en) 2004-02-12
US20040167179A1 (en) 2004-08-26

Similar Documents

Publication Publication Date Title
WO2001020969A3 (en) Use of ribose to prevent cramping and soreness in muscles
WO2005074913A3 (en) Compositions and methods for treating contracture
WO2004098720A3 (en) ‘‘golf swing training device and method of use’’
WO2003007254A3 (en) System and method for providing enhanced services to a user of a gaming application
EP1318777A4 (en) Methods and devices for delivering exogenously generated speech signals to enhance fluency in persons who stutter
DE60226212D1 (en) WEIGHT HOLDING APPARATUS APPLICABLE TO A GOLFER CHAIR HEAD
AU2003243466A1 (en) Method and apparatus for exercise regimen administration
IL162182A (en) Kits containing oral contraceptives and methods utilizing the same
MXPA05006577A (en) Compositions and methods for treating upper respiratory congestion.
GB0419717D0 (en) Improvements in and relating to pelvic floor muscle exercisers & indicators
WO2004012674A3 (en) Development of muscle mass in a mammal
WO2008024431A3 (en) Adult sexual novelty device for those physically challenged
WO2003022882A3 (en) Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
EP1494750A4 (en) Muscle stimulation in cast-immobilized limb
AU2003254600A1 (en) Rehabilitative, recreational, and conditioning facility for swimming, muscle exercise, and mobility improvement
WO2002036210A3 (en) Rotational exercise system, device and method
CN2422987Y (en) Finger spring-grip dumb-bells
Akkari-Ghazouani et al. Effect of Assemblé-Step on Kinetic and Kinematic Parameters of Stag Ring Leaps With and Without Throw-Catch of The Ball in Rhythmic Gymnastics
CN202105379U (en) Moxa-moxibustion muscle tensioning stool
GB9713924D0 (en) A glove,a glove kit for use in playing the game of golf and a method of using the glove kit
GB2435586B (en) Method and apparatus for assisting the user of a sports ball to use spin
CN206526191U (en) A kind of wheelchair with upper limbs exercise function
CN201969268U (en) Strolling machine
Sheehan If the spirit is willing, the flesh will follow
Qing-xiang Developing Capacities of Human Talents and Scientific Concept of Human Talents

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2494506

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003767157

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003767157

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP